• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Transgenic mice carrying hepatitis C Virus genome

Research Project

Project/Area Number 06670522
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Gastroenterology
Research InstitutionUniversity of Tokyo

Principal Investigator

KOIKE Kazuhiko  Tokyo University, Faculty of Medicine, Assistent Proffessor, 医学部(病), 助手 (80240703)

Co-Investigator(Kenkyū-buntansha) MORIYA Kyoji  Tokyo University, Faculty of Medicine, Assistan, Proffesso, 医学部(病), 助手
YOTSUYANAGI Hiroshi  Tokyo University, Faculty of Medicine, 医学部(病), 医員 (30251234)
Project Period (FY) 1994 – 1995
Project Status Completed (Fiscal Year 1995)
Budget Amount *help
¥2,100,000 (Direct Cost: ¥2,100,000)
Fiscal Year 1995: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1994: ¥1,300,000 (Direct Cost: ¥1,300,000)
Keywordshepatitis C virus / envelope proteins / transgenic mice / hepatitis / hepatocellular carcinoma / vaccine
Research Abstract

In an attempt to establish a model for hepatitis C virus infection, we produced transgenic mice by introducing the hepatitis C virus envelope genes, E1 and E2, under the control of a regulatory element from hepatitis B virus. F1-generation mice from the established founders demonstrated expression of both E1 and E2 proteins as glycosylated forms in their organs including the liver. Immunostaining revealed the localization of envelope proteins principally in the cytoplasm of hepatocytes around the hepatic central veins. Furthermore, E1 and E2 proteins were shown by immunoprecipitation to be associated with each other in the mouse liver. There was no evidence of tissue pathology in the mouse liver up to 16 months of age, suggesting that E1 and E2 proteins per se may not have direct pathogenic effects. Our results demonstrate the first successful expression of hepatitis C vircus gene products in the mouse liver and the association of in vivo expressed HCV envelope proteins. This transgenic mouse would be a good model to study the virus-cell interactions of HCV such as intracellular transport and assembly of envelope proteins. Also it may be a good model system to determine the role of these proteins in the pathogenesis of hepatitis or extra-hepatic manifestations in HCV infection with the introduction of cytotoxic T lymphocytes specific for the envelope proteins.

Report

(3 results)
  • 1995 Annual Research Report   Final Research Report Summary
  • 1994 Annual Research Report
  • Research Products

    (18 results)

All Other

All Publications (18 results)

  • [Publications] K. Koike, et al.: "Expression of HCV envelope proteins in transgenic mice." J. Gen. Virol.76. 3031-3038 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] K. Moriya, et al.: "In vivo inhibition of hepatitis B virus gene expression by antisense phosphorathioate oligo deoxynucleotides." Biochem. Biophys. Res. Commun.218. 217-223 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] K. Koike, et al.: "Hepatitis B virus HBx gene and hepatocatcinogenesis." Intervirology. 38. 134-142 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] H. Yotsuyanagi, et al.: "HCV genotypes and development of nepatocellular carcinoma." Cancer. 76. 1352-1355 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] K. Yasuda, et al.: "One-point quantitative determination of pre-treatment serum HCV RNA predicts long-term responsiveness to high-dose IFN therapy." Int. Hepatol. Commun. 3. 144-153 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] K. Koike, et al.: "Dominant replication of either virus in dual infection with hepatitis viruses B and C." J. Med. Virol.45. 236-239 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] K.Koike^*, K.Moriya, K.Ishibasshi, Y.Matsuura, T.Suzuki, I.Saito, S.Iino, K.Kurokawa, T.Miyamura: "Expression of hepatitis C virus envelope proteins in transgenic mice" J Gen Virol. 76. 3031-3038 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] K.Moriya, M.Matsukura, K.Kurokawa, K.Koike^*: "In vivo inhibition of hepatitis B virus gene expression by antisense phosphorothioate oligonucleotides" Biochem Biophys Res Commun. 218. 217-223 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] K.Koike^*.: "Hepatitis B virus HBx gene and hepatocarcinogenesis" Intervirology. 38. 134-142 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] H.Yotsuyanagi, K.Koike^*, K.Yasuda, K.Moriya, K.Hino, K.Kurokawa, S.Iino: "Hepatitis C virus genotypes and development of hepatocellular carcinoma" Cancer. 76. 1352-1355 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] K.Yasuda, K.Koike^*, H.Yotsuyanagi, K.Moriya, T.Maruyama, K.Hino, F.Sugata, K.Kurokawa, S.Iino: "One-point quantitative determination of pre-treatment serum hepatitis C virus RNA predicts long-term responsiveness to high-dose interferon therapy." Int Hepatol Commun. 3. 144-153 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] K.Koike^*, K.Yasuda, H.Yotsuyanagi, K.Moriya, K.Hino, S.Iino, K.Kurokawa: "Dominant replication of either virus in dual infection with hepatitis viruses B and C" J Med Virol. 45. 236-239 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] K.Koike,et al.: "Induction of cell cycle progression by hepatitis B vivus HBx gene expression in quiescent mouse fibroblasts." J Clin Invest. 94. 44-49 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] K.Koike,et al.: "High-level expression of hepatitis B rinus HBx gene and hepato carcinogenesis in transgenic mice." Hepatology. 19. 810-819 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] K.Moriya,et al.: "Induction of interstitial pneumouitis during IFN treatmant for chronic hepatitis C." J Gastroenferol. 29. 514-517 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] T.Maruyama,et al.: "Distingushing between acute and symptomatic chronic hepatitis B virus infection." Gastroenterology. 106. 1006-1015 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] K.Koike,et al.: "Dominant replication of either virus in dual infection with hepatitis viruses B and C." J Med Virol. (in press). (1995)

    • Related Report
      1994 Annual Research Report
  • [Publications] K,Yasuda,et al.: "One-point quantitative determination of pre-treatment serum hepatitis C virus RNA predicts long-term prognosis after high-dose INTERFEROW" Int Hepatol Commun.(in press). (1995)

    • Related Report
      1994 Annual Research Report

URL: 

Published: 1994-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi